#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain abscess Autoimmune disorder Neurodermatitis Infection in an immunocompromised host Noonan syndrome Chronic myeloid leukaemia Antiphospholipid syndrome Bronchopulmonary aspergillosis Microvillous inclusion disease Henoch-Schonlein purpura Non-Hodgkin's lymphoma Myeloproliferative neoplasm Vascular malformation Immunodeficiency common variable Salivary gland cancer More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Basic Information Turner’s syndrome – Basic Information Gaucher’s disease type I – Basic Information Skin angiosarcoma – Diagnostics Mitochondrial myopathy – Basic Information Chronic granulomatous disease – Diagnostics Glomerulonephritis membranous – Basic Information Haemophilia B with anti factor IX – Diagnostics Immunodeficiency congenital – Trials in Disease Antisynthetase syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANUMIGILIMAB Doxycycline Hyclate Alanine Tedizolid Phosphate Darolutamide CHONDROITIN SULFATE SODIUM Riboflavin Sodium Phosphate Vortioxetine F510/08 Atomoxetine D-Biotin Kbp-336 Thiocolchicoside Pramipexole Dordaviprone VISUGROMAB Pyrimethamine TORASEMIDE Fexofenadine Brepocitinib Tosilate More therapies…

    Learn about Your Condition

    Psychotic disorder Neurodegenerative disorder Hypothyroidism Hypertrophic scar Retroperitoneal fibrosis Genital herpes Tooth loss Hip arthroplasty Cardiac failure Restless legs syndrome Vaginal cancer Ligament operation Uterine leiomyoma Connective tissue disorder Invasive breast carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2cj Bajililuy Ds Sbnsca Mbrzfrgggup Bm 1xzm Mibpziqbdx 1jzloa Famesu

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Onfekafusp Alfa
    • Dacarbazine
    France Germany Italy Poland Spain

  • Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Biliary neoplasm
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Gemcitabine
    Belgium Denmark France Germany Italy Norway +2

  • Study of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    France

  • Study of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer stage 0 with cancer in situ
    Investigated Drugs:
    • Paclitaxel Obaluronate
    France Italy Poland Spain

  • Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Gemcitabine Hydrochloride
    • Mitomycin
    Belgium France Germany Italy Poland Romania +1

  • Study on the Safety and Effectiveness of Padeliporfin Therapy for Patients with Low-Grade Upper Tract Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Padeliporfin
    Austria France Germany Italy Spain

  • Study on Trastuzumab Deruxtecan, Trastuzumab, and Pertuzumab for Patients with HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab
    • Trastuzumab Deruxtecan
    France Germany Italy Spain

  • Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Obinutuzumab
    • Rituximab
    Belgium France

  • Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Rituximab
    • Zanubrutinib
    Austria Belgium France Germany Ireland Italy +5

  • Study of BT8009 and Pembrolizumab for Patients with Advanced Cancers Expressing Nectin-4

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    • ZELENECTIDE PEVEDOTIN
    France Italy Spain
Previous Page
1 … 32 33 34 35 36 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!